Is vitamin B12 good for osteoarthritis?

Osteoarthritis (OA) is a degenerative joint condition marked by cartilage loss, pain, and limited mobility. While no vitamin reverses advanced cartilage loss, vitamin B12 (cobalamin) has biological roles that can indirectly influence symptoms and overall joint health. This article summarizes current evidence on B12 in the context of OA and practical considerations for people and clinicians.

How B12 may affect joints and bones

Vitamin B12 is essential for DNA synthesis, myelin maintenance and homocysteine metabolism. Elevated homocysteine has been associated with reduced bone mineral density and increased fracture risk, suggesting that adequate B12 may support skeletal health indirectly. B12 does not form cartilage or bone matrix directly, but it contributes to cellular processes in chondrocytes and osteoblasts that influence tissue maintenance.

Nerve support and pain modulation

Neuropathic symptoms—in the form of burning, tingling, or shooting pain—can co-occur with OA when joint changes compress nearby nerves. Clinical and observational studies show that bioactive forms of B12 (for example, methylcobalamin) can improve nerve conduction and reduce neuropathic pain in some conditions. For OA patients with nerve-related pain, correcting B12 deficiency may therefore reduce symptom burden and improve function.

Inflammation and biochemical effects

OA involves low-grade inflammation of the synovium and cytokine-mediated cartilage breakdown. Laboratory and small clinical studies indicate that B12 can modulate inflammatory cytokines such as TNF-alpha and interleukin-6 in certain settings, though evidence specific to OA joints is limited. These anti-inflammatory effects provide a plausible mechanism whereby sufficient B12 status could modestly influence disease activity or symptom severity.

Deficiency, testing and populations at risk

B12 deficiency is common in older adults and people with conditions or medications that impair absorption. Symptoms such as fatigue, muscle weakness and neuropathy can overlap with OA-related disability. Measuring serum B12 and markers like methylmalonic acid (MMA) helps identify deficiency. For readers seeking more on vitamin D forms relevant to bone health, see this discussion of vitamin D3 versus vitamin D and a summarized primer at the Telegraph explanation of vitamin D forms.

Supplementation considerations

Clinical trials directly testing B12 for OA outcomes are limited, but available data suggest potential benefits for nerve pain and functional mobility when deficiency is corrected. Typical supplemental doses in studies range from 250 to 1000 mcg daily; B12 is water-soluble and generally well tolerated. Combining B12 with other nutrients that support bone and joint health—such as vitamin D and magnesium—may be reasonable. For more about magnesium intake risks and considerations, see this review of taking magnesium without medical need.

Practical summary

Vitamin B12 is not a cure for osteoarthritis, but maintaining adequate B12 status can address overlapping symptoms (notably neuropathic pain and fatigue) and may indirectly support bone and joint health through homocysteine regulation and reduced inflammation. Patients with OA—especially older adults or those on long-term acid-suppressing drugs or metformin—should consider testing and, if deficient, receive appropriate supplementation under clinical guidance. A balanced, evidence-informed approach that considers nutrient interactions and individual needs is recommended. For an in-depth review on this topic, see this review on vitamin B12 and osteoarthritis.